March 7, 2016 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Path Links, a pathology network in Northern Lincolnshire, upgrades to digital pathology to enhance cancer diagnostics capability

Lincoln, UK, 08 March 2016 – Path Links, the single managed NHS clinical pathology service operating across Lincolnshire, has upgraded to digital pathology to continue its focus on providing the highest quality diagnostic services for Northern Lincolnshire & Goole NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust and 186 General Practices across the county. Path... Read more

February 29, 2016 Bio/Pharma/CRO M&A, Partnerships

JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility

WUHAN, China and AMERSHAM, England, Feb. 25, 2016 /PRNewswire/ — JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1 biopharmaceutical manufacturing facility in the Biolake area of Wuhan, China. The campus was built to be compliant with the highest international standards, and after site validation is completed in June... Read more

December 17, 2015 Bio/Pharma/CRO Product Launch

BeiGene selects GE’s FlexFactory™ biomanufacturing platform for pilot cGMP production facility in China

CHALFONT ST. GILES, UK and BEIJING, CHINA – 16 December 2015 – GE Healthcare’s Life Sciences business and BeiGene, Ltd. today announced that BeiGene has selected GE’s FlexFactory™ biomanufacturing platform for its first current Good Manufacturing Practices (cGMP) biomanufacturing facility in Suzhou, China.  Currently under construction, the facility is expected to be operational by 2017.... Read more

December 10, 2015 Bio/Pharma/CRO Licensing, IP, and Legal

NBA and GE Healthcare Leadership Meet on Injury Prevention, Diagnosis and Treatment

WAUWATOSA, Wis., Dec. 7, 2015 – The National Basketball Association (NBA) and GE Healthcare (NYSE: GE) today conducted a successful meeting at GE’s Wisconsin offices to discuss the progress of their research collaboration.  The partnership, which commenced in July, promotes sports medicine research to benefit not only NBA players but athletes of all levels.  Today’s... Read more

December 3, 2015 Bio/Pharma/CRO

GE Healthcare Life Sciences strengthens business resilience with ISO 22301 business continuity accreditation for chromatography media

CHALFONT ST. GILES, UK – 3 December 2015 – GE Healthcare’s Life Sciences business today announced that its chromatography media manufacturing facility and supporting functions in Uppsala, Sweden have been certified to ISO 22301, the international standard for business continuity management systems.  Chromatography medium is a key component in the production of biopharmaceuticals such as... Read more

November 9, 2015 Bio/Pharma/CRO Life Science Tools

It Takes Two: GE Healthcare and SHINE team up to solve longstanding radiopharmaceutical supply concerns in medical imaging

CHALFONT ST. GILES, UK – 9 November 2015 – Technetium-99m (Tc‑99m) is used in more than 40 million medical imaging procedures each year, primarily stress tests to assess heart disease, and bone scans to determine the stage of cancer progression. This essential medical isotope is generated in pharmacies and hospitals from another isotope—molybdenum-99 (Mo-99).  Despite... Read more

February 3, 2015 Bio/Pharma/CRO Product Launch

GE Water & Process Technologies Launches Used to Useful News Site

Feb 3, 2015 – Trevose, PA – GE Analytical Instruments’ parent company GE Water & Process Technologies launched UsedtoUseful, a new platform where we share industry insight and discuss interesting concepts surrounding the impact of water reuse on industrial and municipal sectors. UsedtoUseful focuses on water reuse, tough-to-treat water, energy efficiency, and monitoring through interesting articles, original content, and... Read more